Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.94 USD | -0.96% |
|
-6.07% | +4.13% |
| 12-08 | Why the Fed's Next Move Matters More Than Markets Admit |  |
| 12-08 | Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla… | |
| Capitalization | 139B 120B 112B 104B 192B 12,499B 209B 1,300B 505B 5,924B 522B 511B 21,828B | P/E ratio 2025 * |
45.4x | P/E ratio 2026 * | 36.6x |
|---|---|---|---|---|---|
| Enterprise value | 148B 127B 119B 111B 205B 13,294B 222B 1,383B 538B 6,301B 555B 543B 23,217B | EV / Sales 2025 * |
7.37x | EV / Sales 2026 * | 6.46x |
| Free-Float |
84.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | -0.95% | ||
| 1 week | -6.07% | ||
| Current month | -8.44% | ||
| 1 month | -7.83% | ||
| 3 months | -13.95% | ||
| 6 months | -7.03% | ||
| Current year | +4.13% |
| 1 week | 92.72 |  | 99.34 |
| 1 month | 92.72 | | 105.65 |
| Current year | 85.98 | | 109.5 |
| 1 year | 85.98 | | 109.5 |
| 3 years | 44.35 | | 109.5 |
| 5 years | 33.42 | | 109.5 |
| 10 years | 15.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 60 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 51 | 2025-06-29 |
John Sorenson
COO | Chief Operating Officer | 57 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 60 | 2009-03-31 |
Michael Mahoney
CHM | Chairman | 60 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 73 | 2014-02-28 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.75% | 26 M€ | +11.55% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.96% | -6.07% | +4.84% | +101.19% | 139B | |
| -0.61% | -2.47% | +5.36% | +1.03% | 213B | |
| -1.10% | -1.06% | +4.24% | +107.57% | 201B | |
| -0.16% | -0.90% | -4.82% | -16.63% | 159B | |
| +0.78% | +2.53% | -16.44% | -12.46% | 56.15B | |
| -0.65% | -1.12% | +18.14% | +13.17% | 48.93B | |
| -0.91% | -5.05% | -1.88% | -7.62% | 40.32B | |
| +0.31% | +4.09% | +1.95% | - | 37.85B | |
| -1.04% | -1.16% | +1.30% | +12.86% | 36.44B | |
| -0.67% | -1.44% | -24.39% | -36.72% | 34.22B | |
| Average | -0.55% | -0.91% | -1.17% | +18.04% | 96.6B | |
| Weighted average by Cap. | -0.63% | -1.61% | +1.12% | +34.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.08B 17.25B 16.18B 15.08B 27.77B 1,804B 30.18B 188B 72.94B 855B 75.34B 73.74B 3,150B | 22.37B 19.22B 18.03B 16.8B 30.94B 2,010B 33.63B 209B 81.28B 953B 83.95B 82.17B 3,510B |
| Net income | 3.02B 2.59B 2.43B 2.27B 4.18B 271B 4.54B 28.23B 10.97B 129B 11.33B 11.09B 474B | 3.76B 3.23B 3.03B 2.82B 5.2B 338B 5.65B 35.13B 13.66B 160B 14.1B 13.81B 590B |
| Net Debt | 8.85B 7.6B 7.13B 6.64B 12.24B 795B 13.3B 82.69B 32.14B 377B 33.2B 32.49B 1,388B | 5.45B 4.69B 4.4B 4.1B 7.54B 490B 8.2B 50.97B 19.81B 232B 20.46B 20.03B 856B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-09 | 92.99 $ | -0.90% | 6,828,721 |
| 25-12-08 | 93.84 $ | -3.77% | 14,721,272 |
| 25-12-05 | 97.52 $ | -0.20% | 8,145,496 |
| 25-12-04 | 97.72 $ | -0.86% | 9,407,689 |
| 25-12-03 | 98.57 $ | -0.45% | 9,868,971 |
Delayed Quote Nyse, December 09, 2025 at 02:58 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition